NTAGI approves SII's Covovax COVID vaccine for 12-17 age group: Sources

Apr 29, 2022

New Delhi [India], April 29 : National Technical Advisory Group on Immunisation (NTAGI) on Friday approved Serum Institute of India's Covovax COVID-19 vaccine for...

NTAGI approves Corbevax, Covaxin for 5-12 yrs age group: Sources

Jul 08, 2022

New Delhi [India], July 8 : The National Technical Advisory Group on Immunisation's (NTAGI) Standing Technical Sub-Committee (STSC) has given a nod for the...

SEC recommends granting emergency use authorisation to Serum Institute of India's Covovax COVID-19 vaccine

Mar 04, 2022

New Delhi [India], March 4 : The Subject Expert Committee (SEC) has recommended granting emergency use authorisation (EUA) to Serum India of India's COVID-19...

SEC seeks more data from Serum Institute over COVID vaccine Covovax for 7-12 age group: Sources

Apr 29, 2022

New Delhi [India], April 30 : The Drugs Controller General of India's (DCGI) subject expert committee on Friday sought more data from Pune based...

NTAGI to discuss inclusion of Covovax in CoWIN portal as heterologous booster dose soon

Jan 18, 2023

The National Technical Advisory Group on Immunisation (NTAGI) is likely to meet soon to discuss inclusion of Covid vaccine Covovax on the CoWIN portal...

NTAGI to review data of SII's COVID-19 vaccine Covovax on Friday: Sources

Mar 30, 2022

New Delhi [India], March 30 : The COVID-19 working group of the National Technical Advisory on Immunisation (NTAGI) will be reviewing the data of...